These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 30701683)
1. FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway. Yin L; Fang Y; Song T; Lv D; Wang Z; Zhu L; Zhao Z; Yin X J Cell Mol Med; 2019 Apr; 23(4):2558-2567. PubMed ID: 30701683 [TBL] [Abstract][Full Text] [Related]
2. CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Ma ZG; Yuan YP; Xu SC; Wei WY; Xu CR; Zhang X; Wu QQ; Liao HH; Ni J; Tang QZ Diabetologia; 2017 Jun; 60(6):1126-1137. PubMed ID: 28258411 [TBL] [Abstract][Full Text] [Related]
3. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy. Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes. Mangali S; Bhat A; Jadhav K; Kalra J; Sriram D; Vamsi Krishna Venuganti V; Dhar A Biochem Pharmacol; 2020 Jul; 177():113948. PubMed ID: 32251680 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β. Wu W; Liu X; Han L Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226 [TBL] [Abstract][Full Text] [Related]
8. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats. Diao J; Wei J; Yan R; Fan G; Lin L; Chen M J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723 [TBL] [Abstract][Full Text] [Related]
9. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway. Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390 [TBL] [Abstract][Full Text] [Related]
10. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195 [TBL] [Abstract][Full Text] [Related]
11. The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification. Li M; Chen L; Liu X; Wu Y; Chen X; Chen H; Zhong Y; Xu Y Biomed Pharmacother; 2024 Aug; 177():117048. PubMed ID: 38959606 [TBL] [Abstract][Full Text] [Related]
12. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. Liu X; Guo B; Zhang W; Ma B; Li Y J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411 [TBL] [Abstract][Full Text] [Related]
13. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386 [TBL] [Abstract][Full Text] [Related]
14. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling. Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228 [TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress. Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy. Zhang M; Wang X; Liu M; Liu D; Pan J; Tian J; Jin T; Xu Y; An F J Cell Mol Med; 2020 Apr; 24(8):4612-4623. PubMed ID: 32150791 [TBL] [Abstract][Full Text] [Related]
17. Nimbolide protects against diabetic cardiomyopathy by regulating endoplasmic reticulum stress and mitochondrial function via the Akt/mTOR pathway. Zhang H; Zhao X; Wei W; Shen C Tissue Cell; 2024 Oct; 90():102478. PubMed ID: 39053131 [TBL] [Abstract][Full Text] [Related]
18. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674 [TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354 [TBL] [Abstract][Full Text] [Related]
20. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy. Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]